Jack Nathan Medical Corp.
JNHMF
$0.0036
-$0.0001-2.70%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.75% | -48.45% | -48.36% | -50.05% | -56.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.75% | -48.45% | -48.36% | -50.05% | -56.35% |
| Cost of Revenue | -19.53% | -61.58% | -51.76% | -41.16% | -49.57% |
| Gross Profit | 29.96% | -44.38% | -47.39% | -52.29% | -58.00% |
| SG&A Expenses | 25.20% | -35.60% | -38.43% | -46.97% | -57.28% |
| Depreciation & Amortization | -13.00% | -65.33% | -75.76% | -69.76% | -72.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.24% | -41.36% | -42.41% | -47.11% | -56.96% |
| Operating Income | -8.26% | 15.31% | 20.81% | 37.45% | 58.77% |
| Income Before Tax | -10.38% | 52.04% | 39.35% | 49.71% | 69.71% |
| Income Tax Expenses | -- | 71.40% | 71.40% | 74.83% | -- |
| Earnings from Continuing Operations | -67.74% | 62.19% | 51.22% | 61.79% | 80.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 208.16% | -5.68% | -29.09% | -19.67% | 5.75% |
| EBIT | -8.26% | 15.31% | 20.81% | 37.45% | 58.77% |
| EBITDA | -20.64% | 21.79% | 24.63% | 47.39% | 71.16% |
| EPS Basic | 205.88% | -3.68% | -26.91% | -18.10% | 6.77% |
| Normalized Basic EPS | -8.47% | 14.24% | 10.74% | 37.98% | 62.18% |
| EPS Diluted | 200.84% | -0.86% | -22.45% | -13.95% | 12.97% |
| Normalized Diluted EPS | 9.17% | 15.88% | 12.31% | 40.77% | 61.54% |
| Average Basic Shares Outstanding | 2.45% | 2.05% | 2.10% | 1.67% | 1.11% |
| Average Diluted Shares Outstanding | 5.57% | 5.09% | 4.92% | 6.51% | 3.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |